Envonalkib
Envonalkib is a pharmaceutical drug for cancer treatment. It belongs to the class of anaplastic lymphoma kinase inhibitors.
In China, it is approved for the treatment of patients with ALK-positive locally advanced or metastatic non-small cell lung cancer who have not received treatment with ALK inhibitors.